Malcolm Ronald Starkey
Malcolm Ronald Starkey
Group Leader Immunology and Regenerative Medicine, Australian Research Council Discovery Early
Verified email at - Homepage
TitleCited byYear
Early-life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology
JC Horvat, MR Starkey, RY Kim, S Phipps, PG Gibson, KW Beagley, ...
Journal of Allergy and Clinical Immunology 125 (3), 617-625. e6, 2010
Chlamydial respiratory infection during allergen sensitization drives neutrophilic allergic airways disease
JC Horvat, MR Starkey, RY Kim, KW Beagley, JA Preston, PG Gibson, ...
The Journal of Immunology 184 (8), 4159-4169, 2010
Role for NLRP3 inflammasome–mediated, IL-1β–dependent responses in severe, steroid-resistant asthma
RY Kim, JW Pinkerton, AT Essilfie, AAB Robertson, KJ Baines, AC Brown, ...
American journal of respiratory and critical care medicine 196 (3), 283-297, 2017
Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T-cells
JA Preston, AN Thorburn, MR Starkey, EL Beckett, JC Horvat, MA Wade, ...
European Respiratory Journal 37 (1), 53-64, 2011
Targeting PI3K-p110α suppresses influenza virus infection in chronic obstructive pulmonary disease
A Chen-Yu Hsu, MR Starkey, I Hanish, K Parsons, TJ Haw, LJ Howland, ...
American journal of respiratory and critical care medicine 191 (9), 1012-1023, 2015
MicroRNA-21 drives severe, steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase–mediated suppression of histone deacetylase 2
RY Kim, JC Horvat, JW Pinkerton, MR Starkey, AT Essilfie, JR Mayall, ...
Journal of Allergy and Clinical Immunology 139 (2), 519-532, 2017
Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma
AT Essilfie, JC Horvat, RY Kim, JR Mayall, JW Pinkerton, EL Beckett, ...
Thorax 70 (5), 458-467, 2015
TLR2, but not TLR4, is required for effective host defence against Chlamydia respiratory tract infection in early life
EL Beckett, S Phipps, MR Starkey, JC Horvat, KW Beagley, PS Foster, ...
PloS one 7 (6), e39460, 2012
Th2 cytokine antagonists: potential treatments for severe asthma
PM Hansbro, GV Scott, AT Essilfie, RY Kim, MR Starkey, DH Nguyen, ...
Expert Opinion on Investigational Drugs 22 (1), 49-69, 2013
Constitutive production of IL-13 promotes early-life Chlamydia respiratory infection and allergic airway disease
MR Starkey, AT Essilfie, JC Horvat, RY Kim, DH Nguyen, KW Beagley, ...
Mucosal immunology 6 (3), 569, 2013
Murine models of infectious exacerbations of airway inflammation
MR Starkey, AG Jarnicki, AT Essilfie, SL Gellatly, RY Kim, AC Brown, ...
Current opinion in pharmacology 13 (3), 337-344, 2013
Tumor necrosis factor-related apoptosis-inducing ligand translates neonatal respiratory infection into chronic lung disease
MR Starkey, DH Nguyen, AT Essilfie, RY Kim, LM Hatchwell, AM Collison, ...
Mucosal immunology 7 (3), 478, 2014
A pathogenic role for tumor necrosis factor-related apoptosis-inducing ligand in chronic obstructive pulmonary disease
TJ Haw, MR Starkey, PM Nair, S Pavlidis, G Liu, DH Nguyen, AC Hsu, ...
Mucosal immunology 9 (4), 859, 2016
Mechanisms and treatments for severe, steroid‐resistant allergic airway disease and asthma
PM Hansbro, RY Kim, MR Starkey, C Donovan, K Dua, JR Mayall, G Liu, ...
Immunological reviews 278 (1), 41-62, 2017
MicroRNA-125a and-b inhibit A20 and MAVS to promote inflammation and impair antiviral response in COPD
ACY Hsu, K Dua, MR Starkey, TJ Haw, PM Nair, K Nichol, N Zammit, ...
JCI insight 2 (7), 2017
Mucosal production of uric acid by airway epithelial cells contributes to particulate matter-induced allergic sensitization
MJ Gold, PR Hiebert, HY Park, D Stefanowicz, A Le, MR Starkey, A Deane, ...
Mucosal immunology 9 (3), 809, 2016
Chlamydia muridarum lung infection in infants alters hematopoietic cells to promote allergic airway disease in mice
MR Starkey, RY Kim, EL Beckett, HC Schilter, D Shim, AT Essilfie, ...
PLoS One 7 (8), e42588, 2012
Suppressor of cytokine signaling (SOCS) 5 ameliorates influenza infection via inhibition of EGFR signaling
L Kedzierski, MD Tate, AC Hsu, TB Kolesnik, EM Linossi, L Dagley, ...
Elife 6, e20444, 2017
The MIF Antagonist ISO-1 Attenuates Corticosteroid-Insensitive Inflammation and Airways Hyperresponsiveness in an Ozone-Induced Model of COPD.
KE Russell, KF Chung, CJ Clarke, AL Durham, P Mallia, J Footitt, ...
PloS one 11 (1), e0146102, 2016
Endosomal NOX2 oxidase exacerbates virus pathogenicity and is a target for antiviral therapy
EE To, R Vlahos, R Luong, ML Halls, PC Reading, PT King, C Chan, ...
Nature communications 8 (1), 69, 2017
The system can't perform the operation now. Try again later.
Articles 1–20